FDA approves expanded use of inclisiran for primary hyperlipidemia Dr. Kamal Kant Kohli13 July 2023 10:00 AM ISTThe US Food and Drug Administration has approved expanded use of inclisiran (Leqvio) for primary hyperlipidemia besides its existing indications of...
Novartis halts UK trial of anticholesterol drug Leqvio Dr. Nandita Mohan23 March 2023 6:00 PM ISTNovartis said on Wednesday that it had decided not to move forward with ORION-17, the UK-based primary prevention trial originally planned as part of...
Health Bulletin 23/March/2023 Dr. Nandita Mohan23 March 2023 4:25 PM ISTHere are the top health stories for the day:New Bond Policy: Gujarat proposes 1.5 years of mandatory service for doctors completing MBBS, PG...
Novartis not to move ahead with UK trial of anti-cholesterol drug Leqvio Ruchika Sharma22 March 2023 4:00 PM ISTBerlin: Novartis said on Wednesday that it had decided not to move forward with ORION-17, the UK-based primary prevention trial originally...
Novartis to prioritise US market, unfazed by drug pricing pushback Ruchika Sharma25 Sept 2022 2:51 PM ISTNovartis aspire to "organically build its U.S. business to become a top-five player in the U.S. by 2027," it said in a statement.
Novartis proposal to market Inclisiran with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team24 Oct 2021 11:30 AM ISTNew Delhi: Rejecting Novartis Healthcare's proposal to import and market Inclisiran Solution for Injection with a local clinical trial waiver,...
